A biomolecular engineering course has recently been redesigned to give students experience with the entire process of DNA sequencing, from sampling to data analysis, using the latest nanopore devices ...

The DNA of human cells consists of a sequence of about 3.1 billion building blocks. Cells go to great lengths to maintain the ...

Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

Gene therapy for cystic fibrosis is advancing fast. Explore key biotech players, clinical progress, and its potential to ...

Researchers from Agency for Science, Technology and Research in Singapore recently published a review article exploring how ...

Discover the latest advancements in science, from AI in medicine to gene editing technology, at We-Gnana 2025 science fest.

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

Oncolytic adenovirus was engineered for the forced ectopic delivery of peptide-MHC ligand of T cell receptors (TCRs) to ...

A revolution is underway in gene editing—and at its forefront is David Liu, an American molecular biologist whose pioneering ...

Heidelberg biochemists and structural biologists from Shanghai unravel the roles of two key regulatory factors in mRNA ...

Learn more about whether Moderna, Inc. or Twist Bioscience Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Johns Hopkins Medicine scientists say they have found a pattern of so-called epigenetic "marks" in a transition state between ...